company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,882000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,882000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,250000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,250000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,632000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,914000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3356000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4270000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3638000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3638000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3634000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3634000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3634000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,400000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-9.84
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,400000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-9.84
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,369460.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q2,2013-04-01,2013-06-30,2014-09-08 16:58:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-9.84
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,129000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,129000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,70000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,70000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,59000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1132000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2920000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4052000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3993000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3993000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3994000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3994000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3994000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,400000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.81
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,400000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.81
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,369460.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:26:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.81
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1446000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4078000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5524000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5513000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2711000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2711000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8224000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8223000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8223000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8223000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,400000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-22.25
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,400000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-22.25
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,369656.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-22.25
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1064000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1064000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1046000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1850000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3883000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5733000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4687000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1439000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1439000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6126000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6126000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6126000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6126000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,400000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-16.57
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,400000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-16.57
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,369750.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:09:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-16.57
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3544000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3544000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3513000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4082000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5988000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10070000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6557000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-127000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-127000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6684000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6682000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6682000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6682000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12100000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12100000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12128810.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:15:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1800000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1800000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,575000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,575000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1225000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5549000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8797000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14346000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13121000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13121000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13120000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13120000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13120000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7500000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,34.81
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7500000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,34.81
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7494790.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,34.81
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1849000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1938000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,79000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,79000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1859000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3802000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7463000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11265000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9406000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9406000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9406000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9406000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9406000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16800000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16800000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16944871.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1761000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1780000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1736000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3778000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8483000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12261000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10525000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10525000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,8000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10517000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10517000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10517000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19500000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19500000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19356404.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:28:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4324000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,329000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4653000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,298000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,298000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4355000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3506000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8263000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11769000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7414000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7414000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,7000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7407000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7407000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7407000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20000000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20000000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20131260.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:42:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5078000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-3939000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1139000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,353000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,353000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,786000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4048000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8878000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12926000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12140000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12140000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,25000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12115000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12115000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12115000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19100000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19100000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19155918.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1856000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1863000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1841000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3914000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10570000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14484000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12643000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12643000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,349000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12294000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12294000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12294000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20200000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20200000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20153202.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,733000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,400000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1133000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,253000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,253000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,880000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3948000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11386000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15334000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14454000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14454000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,107000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14347000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14347000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14347000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20200000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20200000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20155410.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:37:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7426000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,780000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8206000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,72000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,72000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8134000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9554000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11173000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20727000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12593000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12593000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,150000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12443000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12443000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12443000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20700000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20700000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20803776.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:41:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5094000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-3036000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2058000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,134000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,134000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1924000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4443000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12005000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16448000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14524000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14524000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,78000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14446000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14446000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14446000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21700000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21700000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21638468.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5465000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5465000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5428000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4135000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14038000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18173000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12745000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12745000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,125000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12620000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12620000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12620000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25200000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25200000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25463202.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,729000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,729000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,711000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3888000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10863000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14751000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14040000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14040000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,194000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13846000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13846000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13846000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25600000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25600000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25567482.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 17:13:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,516000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,516000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,500000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3909000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10246000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14155000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13655000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13655000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,239000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13416000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13416000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13416000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25800000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25800000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25620781.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:36:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,485000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,485000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,472000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4321000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8523000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12844000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12372000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12372000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,392000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11980000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11980000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11980000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29626941.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,503000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,503000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,496000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3995000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10311000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14306000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13810000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13810000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,510000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13300000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13300000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13300000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47500000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47500000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48122396.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,755000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,755000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,140000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,140000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,615000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4006000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11000000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15006000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14391000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14391000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,583000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13808000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13808000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13808000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47600000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47600000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48125652.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,2018-08-01 17:13:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,462000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,462000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,430000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3802000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11268000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15070000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14640000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14640000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,591000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14049000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14049000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14049000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48400000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48400000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48164828.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,2018-11-06 16:36:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,476000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,476000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1256000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1256000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-780000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3593000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9836000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13429000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14209000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14209000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,608000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13601000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13601000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13601000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48000000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48000000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48145225.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
